
Airway Medix S.A.
Other research and experimental development on natural sciences and engineering
Overview
Airway Medix develops single-use respiratory devices for intensive care, operating rooms and anaesthesia. Its products include the B-Care Oral Care kit and AWM Cuffix cuff pressure regulator; the company is also developing a closed suction system and HyperForm mask.
Financials
Revenue history (in k)
Filing timeliness
4 of 6 financial statements were filed late (the longest delay 105 days for 2023). All were audited by a statutory auditor.
- 202531/08/2026
- 202408/10/2025
- 202328/10/2024
- 202217/07/2023
- 202104/07/2022
- 202009/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Stock quotes
- Open
- PLN 0.23
- High
- PLN 0.23
- Low
- PLN 0.23
- Volume
- 82.14K
- Avg. vol.
- 119.42K
- Market cap
- PLN 26.48M
- P/E ratio
- –
- EPS
- -PLN 0.07
- Shares outstanding
- 115.11M
- 52-week
- PLN 0.23 – 0.26
- Dividend yield
- –
- Dividend
- –
- Ex dividend date
- –
- ISIN
- PLAIRWY00017
- Exchange
- GPW Main Market
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q2 2026 | USD 15.67k | USD -309.29k | USD -438.14k |
| Q1 2026 | USD 22.96k | USD -230.96k | USD -415.72k |
| Q4 2025 | USD 1.00k | USD -336.51k | USD -587.14k |
| Q3 2025 | USD -2.26k | USD -445.50k | USD -532.65k |
Results for Q3 2026:Nov 23, 2026
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News
Airway Medix Successfully Completes First Surveillance Audit, Maintains ISO 13485 Certification
The information presented on this website relates to medical devices and is intended exclusively for healthcare professionals and other persons professionally involved in the distribution or use of medical devices.
Update on the ISO 13485 certification process
Information on the conversion of bond receivables owed to Adiuvo Investments S.A. into shares
Airway Medix Announces Leadership Transition as Anna Aranowska-Bablok Steps Down as CEO
The information presented on this website relates to medical devices and is intended exclusively for healthcare professionals and other persons professionally involved in the distribution or use of medical devices.
Industry
Offer
- Oral care kit
- Cuff pressure regulator
- Closed suction system
- Medical mask
Website technology
- Website
- Next.js
Trademarks
The company holds 1 active trademark registered with the Polish Patent Office. 3 marks have expired or were not registered. The first mark was filed in 2015.
| Mark | Protected until | |
|---|---|---|
| Cuffix (word) | Dec 20, 2026 | |
| SweepAir (word) | – | |
| Airway Medix | – | |
| AIRWAY MEDIX (word) | – |
Authorized Representatives
Manner of representation
Each member of the management board has the right to represent the company independently.
Supervisory board
Beneficial owners
Airway Medix is a public company listed on the Warsaw Stock Exchange, so it does not report beneficial owners to the CRBR (Art. 58 of the Polish AML Act). Its shareholders are disclosed in stock-exchange reports.
Bank accounts
Registered as a VAT taxpayer on 2013-08-19.
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jun 5, 2014 | Shareholders' meeting convened | |
| Jan 16, 2014 | Shareholders' meeting convened | |
| Oct 10, 2013 | Commercial Companies Code notice |
Public aid
5 public aid cases recorded, with a total value of $78,539.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 1, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| SUMI sp. z o.o. + limited partnership | $11,618,230.43 | sumi.com.pl | ||
| Extrudan sp. z o.o. | $8,241,066.38 | extrudan.com | ||
| Margomed S.A. | $6,360,594.28 | margomed.com | ||
| Dina-Hitex Polska sp. z o.o. | $3,582,181.68 | dina-hitex.pl | ||
| Prino-Plast sp. z o.o. | $3,250,767.43 | prino-plast.pl | ||
| Neoset sp. z o.o. | $2,972,841.36 | neoset.com.pl | ||
| Steriwund sp. z o.o. | $2,832,891.51 | steriwund.pl | ||
| Advance Europe Biuro Techniczno - Handlowe sp. z o.o. | $2,781,347.45 | advanceeurope.com.pl | ||
| Mustaf Medical sp. z o.o. | $1,215,507.17 | mustaf-medical.pl | ||
| Przedsiębiorstwo Produkcyjno-Handlowe Def-Pol sp. z o.o. | $809,644.85 | def-pol.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-11-05 | Address change (Ul. Szara 10, 00-420, Warszawa → Ul. Łucka 15/212, 00-842, Warszawa) | |
| 2025-06-25 | Share capital increase (25,064,270.96 PLN → 34,501,002.58 PLN) | |
| 2024-06-24 | Share capital increase (24,724,270.96 PLN → 25,064,270.96 PLN) | |
| 2024-04-18 | Address change (Ul. Gen. Józefa Zajączka 11/14, 01-510, Warszawa → Ul. Szara 10, 00-420, Warszawa) | |
| 2024-01-22 | Share capital increase (20,780,270.96 PLN → 24,724,270.96 PLN) |
FAQ
Last updated: 2026-11-05
